{ "api_version": "1", "request": { "url": "https://clinicaltrialsfind.com/api/v1/search.json?intervention=Placebo-MGN", "query": { "intervention": "Placebo-MGN" }, "page_size": 10 }, "pagination": { "page": 1, "page_size": 10, "total_count": 7, "total_pages": 1, "next_page_url": null, "previous_page_url": null }, "source": "remote", "last_synced_at": "2026-09-03T08:20:07.239Z", "attribution": "Data derived from public ClinicalTrials.gov records. The official record at https://clinicaltrials.gov/ remains the source of truth for current availability, contacts, and full study details.", "notes": [ "This endpoint exposes only public summary fields — no participant contact emails, phone numbers, or scraped investigator contact details.", "For contact information and full protocol detail, follow each trial's `official_url` to the ClinicalTrials.gov record.", "This API is a navigational aid. It does not provide medical advice, eligibility determinations, or compensation guarantees." ], "trials": [ { "nct_id": "NCT03285711", "title": "Study to Evaluate the Safety and Efficacy of Filgotinib and Lanraplenib in Adults With Lupus Membranous Nephropathy (LMN)", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Lupus Membranous Nephropathy" ], "interventions": [ { "name": "Filgotinib", "type": "DRUG" }, { "name": "Lanraplenib", "type": "DRUG" }, { "name": "Filgotinib placebo", "type": "DRUG" }, { "name": "Lanraplenib placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Gilead Sciences", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 9, "start_date": "2017-10-06", "completion_date": "2020-02-03", "has_results": true, "last_update_posted_date": "2020-05-18", "last_synced_at": "2026-09-03T08:20:07.239Z", "location_count": 7, "location_summary": "Birmingham, Alabama • Palo Alto, California • Gainesville, Florida + 4 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Palo Alto", "state": "California" }, { "city": "Gainesville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Lawrenceville", "state": "Georgia" } ], "official_url": "https://clinicaltrials.gov/study/NCT03285711" }, { "nct_id": "NCT07157787", "title": "Study of ALXN1920 in Adult Participants With Primary Membranous Nephropathy (PMN)", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Primary Membranous Nephropathy" ], "interventions": [ { "name": "ALXN1920", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Alexion Pharmaceuticals, Inc.", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 30, "start_date": "2025-09-19", "completion_date": "2027-07-09", "has_results": false, "last_update_posted_date": "2026-06-18", "last_synced_at": "2026-09-03T08:20:07.239Z", "location_count": 5, "location_summary": "Loma Linda, California • San Diego, California • Minneapolis, Minnesota + 2 more", "locations": [ { "city": "Loma Linda", "state": "California" }, { "city": "San Diego", "state": "California" }, { "city": "Minneapolis", "state": "Minnesota" }, { "city": "Rochester", "state": "Minnesota" }, { "city": "Houston", "state": "Texas" } ], "official_url": "https://clinicaltrials.gov/study/NCT07157787" }, { "nct_id": "NCT03949855", "title": "Belimumab With Rituximab for Primary Membranous Nephropathy", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Membranous Nephropathy", "Nephrotic Syndrome" ], "interventions": [ { "name": "Belimumab", "type": "DRUG" }, { "name": "Placebo for Belimumab", "type": "DRUG" }, { "name": "Rituximab", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "National Institute of Allergy and Infectious Diseases (NIAID)", "sponsor_class": "NIH", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 58, "start_date": "2020-03-06", "completion_date": "2030-03-01", "has_results": false, "last_update_posted_date": "2026-07-21", "last_synced_at": "2026-09-03T08:20:07.239Z", "location_count": 20, "location_summary": "Birmingham, Alabama • Little Rock, Arkansas • San Francisco, California + 17 more", "locations": [ { "city": "Birmingham", "state": "Alabama" }, { "city": "Little Rock", "state": "Arkansas" }, { "city": "San Francisco", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Torrance", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT03949855" }, { "nct_id": "NCT07355296", "title": "PODOMOUNT-Basket, a Study to Test Whether BI 764198 Helps Adults and Adolescents With Different Types of Kidney Disease", "overall_status": "RECRUITING", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Proteinuric Kidney Diseases" ], "interventions": [ { "name": "BI 764198", "type": "DRUG" }, { "name": "Placebo matching BI 764198", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Boehringer Ingelheim", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "12 Years", "maximum_age": null, "sex": "ALL", "summary": "12 Years and older" }, "enrollment_count": 132, "start_date": "2026-03-23", "completion_date": "2028-02-17", "has_results": false, "last_update_posted_date": "2026-09-02", "last_synced_at": "2026-09-03T08:20:07.239Z", "location_count": 26, "location_summary": "Huntsville, Alabama • Glendale, California • Granada Hills, California + 22 more", "locations": [ { "city": "Huntsville", "state": "Alabama" }, { "city": "Glendale", "state": "California" }, { "city": "Granada Hills", "state": "California" }, { "city": "Los Angeles", "state": "California" }, { "city": "Los Angeles", "state": "California" } ], "official_url": "https://clinicaltrials.gov/study/NCT07355296" }, { "nct_id": "NCT01762852", "title": "Efficacy and Safety Study of Intravenous Belimumab Versus Placebo in Subjects With Idiopathic Membranous Nephropathy", "overall_status": "WITHDRAWN", "study_type": "INTERVENTIONAL", "phases": [ "PHASE2" ], "conditions": [ "Glomerulonephritis, Membranous" ], "interventions": [ { "name": "Belimumab 10 mg", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "GlaxoSmithKline", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": "75 Years", "sex": "ALL", "summary": "18 Years to 75 Years" }, "enrollment_count": 0, "start_date": "2013-04", "completion_date": "2014-01", "has_results": false, "last_update_posted_date": "2017-03-22", "last_synced_at": "2026-09-03T08:20:07.239Z", "location_count": 2, "location_summary": "St Louis, Missouri • Chapel Hill, North Carolina", "locations": [ { "city": "St Louis", "state": "Missouri" }, { "city": "Chapel Hill", "state": "North Carolina" } ], "official_url": "https://clinicaltrials.gov/study/NCT01762852" }, { "nct_id": "NCT01982747", "title": "A Phase I Study to Assess Cardiac and General Safety and Pharmacokinetics of 60 mg MGN1703", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE1" ], "conditions": [ "Healthy" ], "interventions": [ { "name": "MGN-Placebo", "type": "DRUG" }, { "name": "Placebo-MGN", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mologen AG", "sponsor_class": "INDUSTRY", "healthy_volunteers": true, "eligibility": { "minimum_age": "18 Years", "maximum_age": "65 Years", "sex": "ALL", "summary": "18 Years to 65 Years" }, "enrollment_count": 14, "start_date": "2013-11", "completion_date": "2013-12", "has_results": false, "last_update_posted_date": "2014-05-19", "last_synced_at": "2026-09-03T08:20:07.239Z", "location_count": 1, "location_summary": "West Bend, Wisconsin", "locations": [ { "city": "West Bend", "state": "Wisconsin" } ], "official_url": "https://clinicaltrials.gov/study/NCT01982747" }, { "nct_id": "NCT01386554", "title": "Acthar for Treatment of Proteinuria in Membranous Nephropathy Patients", "overall_status": "COMPLETED", "study_type": "INTERVENTIONAL", "phases": [ "PHASE4" ], "conditions": [ "Proteinuria", "Idiopathic Membranous Nephropathy" ], "interventions": [ { "name": "Repository Corticotropin Injection", "type": "DRUG" }, { "name": "Placebo", "type": "DRUG" } ], "intervention_types": [ "DRUG" ], "sponsor": "Mallinckrodt", "sponsor_class": "INDUSTRY", "healthy_volunteers": false, "eligibility": { "minimum_age": "18 Years", "maximum_age": null, "sex": "ALL", "summary": "18 Years and older" }, "enrollment_count": 60, "start_date": "2011-08", "completion_date": "2017-05-05", "has_results": true, "last_update_posted_date": "2019-11-20", "last_synced_at": "2026-09-03T08:20:07.239Z", "location_count": 14, "location_summary": "Sacramento, California • Stanford, California • Jacksonville, Florida + 11 more", "locations": [ { "city": "Sacramento", "state": "California" }, { "city": "Stanford", "state": "California" }, { "city": "Jacksonville", "state": "Florida" }, { "city": "Atlanta", "state": "Georgia" }, { "city": "Rochester", "state": "Minnesota" } ], "official_url": "https://clinicaltrials.gov/study/NCT01386554" } ] }